| 2025-10-01 |
复牌提示：
2025-10-01 11:51:17 停牌，复牌日期 2025-10-01 11:56:17
|
| 2025-10-01 |
详情>>
业绩披露：
2025年中报每股收益-1.17美元,归母净利润-81.5万美元,同比去年增长69.62%
|
| 2025-09-18 |
详情>>
股本变动：
变动后总股本72.83万股
|
| 2025-08-22 |
详情>>
拆分方案：
每3.1250合并分成1.0000股
|
| 2025-08-08 |
股东大会：
将于2025-08-29召开股东大会
会议内容 ▼▲
- 1.To consider and, if deemed appropriate, pass a special resolution, the full text of which is set out in the Information Circular (as defined below), approving, in one or more amendments to the articles of the Corporation determined to be in the best interest of the Corporation by the Board of Directors and in accordance with the terms of the Share Exchange Agreement to:
(i)create a class of special common shares (the “Class A Special Shares”);
(ii)make certain amendments to the existing classes of shares to accommodate the rights associated with the Class A Special Shares;
(iii)create a class of special common shares (the “Class B Special Shares”);
(iv)make certain amendments to the existing classes of shares to accommodate the rights associated with the Class B Special Shares;
(v)create a new class of “blank cheque” preferred shares without par value, issuable in series (the “Class A Preferred Shares”);
(vi)make certain amendments to the existing classes of shares to accommodate the rights associated with the Class A Preferred Shares;
2.To transact such further or other business as may properly come before the Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2025-04-30 |
详情>>
业绩披露：
2024年年报每股收益-3.93美元,归母净利润-409.6万美元,同比去年增长87.31%
|
| 2025-04-16 |
股东大会：
将于2025-04-30召开股东大会
会议内容 ▼▲
- 1.To receive the audited consolidated financial statements of the Corporation for the year ended December 31, 2024, together with the auditors’ report thereon;
2.To fix the number of directors at five;
3.To elect the directors of the Corporation for the ensuing year;
4.To appoint GreenGrowth CPAs as the auditors of the Corporation for the ensuing year and to authorize the audit committee of the board of directors of the Corporation (the “Board”) to fix their remuneration and terms of engagement;
5.To consider and, if deemed appropriate, pass a special resolution, the full text of which is set out in the Information Circular (as defined below), approving one or more amendments to the articles of the Corporation for one or more future consolidations of the Corporation’s issued and outstanding Common Shares on the basis of consolidation ratios to be selected by the Board within a range between two pre-consolidation Common Shares for one post-consolidation Common Share and 100 pre-consolidation Common Shares for one post-consolidation Common Share, provided that, (A) the cumulative effect of the one or more consolidations shall not result in a consolidation ratio that exceeds 100 pre-consolidation Common Shares for one post-consolidation Common Share, and (B) such consolidations occurs prior to the earlier of the 12-month anniversary of the Meeting and the next annual meeting of Shareholders; if, and at such time(s) following the date of the Meeting, as may be determined by the Board in its sole discretion, as more particularly described in the Information Circular (the “Share Consolidation Resolution”);
6.To transact such further or other business as may properly come before the Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2024-11-14 |
详情>>
拆分方案：
每2.0000合并分成1.0000股
|
| 2024-10-30 |
详情>>
业绩披露：
2024年中报每股收益-2.84美元,归母净利润-268.29万美元,同比去年增长54.36%
|
| 2024-10-30 |
详情>>
业绩披露：
2023年中报每股收益-58.35美元,归母净利润-587.79万美元,同比去年增长-126.62%
|
| 2024-05-22 |
详情>>
拆分方案：
每40.0000合并分成1.0000股
|
| 2024-05-01 |
详情>>
业绩披露：
2023年年报每股收益-7.16美元,归母净利润-3227.51万美元,同比去年增长-176.86%
|
| 2024-03-11 |
股东大会：
将于2024-03-22召开股东大会
会议内容 ▼▲
- 1.To receive the audited consolidated financial statements of the Corporation for the year ended December 31, 2022, together with the auditors’ report thereon.
2.To elect the directors of the Corporation for the ensuing year.
3.To appoint GreenGrowth CPAs as the auditors of the Corporation for the ensuing year and to authorize the audit committee of the board of directors of the Corporation (the “Board”) to fix their remuneration and terms of engagement.
4.To consider and, if deemed appropriate, pass a special resolution, the full text of which is set out in the Information Circular (as defined below), approving one or more amendments to the articles of the Corporation for one or more future consolidations of the Corporation’s issued and outstanding Common Shares on the basis of consolidation ratios to be selected by the Board within a range between 10 pre-consolidation Common Shares for one (1) post-consolidation Common Share and 100 pre-consolidation Common Shares for one (1) post-consolidation Common Share, provided that, (A) the cumulative effect of the one or more consolidations shall not result in a consolidation ratio that exceeds 100 pre-consolidation Common Shares for one (1) post- consolidation Common Share, and (B) such consolidations occurs prior to the earlier of the 12-month anniversary of the Meeting and the next annual meeting of Shareholders; if, and at such time(s) following the date of the Meeting, as may be determined by the Board in its sole discretion, as more particularly described in the Information Circular (the “Share Consolidation Resolution”).
5.To consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution confirming and approving the 30% evergreen equity incentive plan of the Corporation (the “Equity Incentive Plan Resolution”).
6.To consider, and if deemed advisable, to pass, with or without variation, a special resolution (the “Transaction Resolution”), authorizing and approving the sale of all the issued and outstanding shares of RPK Biopharma, Unipessoal, LDA (“RPK”) on the terms and subject to the conditions contained in a share purchase agreement, dated as of February 28, 2024, between the Corporation, Cannahealth Limited, Holigen Holdings Limited and Somai Pharmaceuticals Unipessoal, Lda. (the “Share Purchase Agreement”), a copy of which is attached as Schedule “B” to this Information Circular.
7.To transact such further or other business as may properly come before the Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2023-05-02 |
详情>>
业绩披露：
2022年年报每股收益-0.39美元,归母净利润-1165.77万美元,同比去年增长-43.37%
|
| 2023-03-09 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2023-01-04 |
详情>>
业绩披露：
2022年中报每股收益-0.1美元,归母净利润-259.37万美元,同比去年增长-55.1%
|
| 2022-11-14 |
股东大会：
将于2022-11-22召开股东大会
会议内容 ▼▲
- 1.To receive the audited consolidated financial statements of the Corporation for the year ended December 31, 2021, together with the auditors' report thereon.
2.To elect the directors of the Corporation for the ensuing year.
3.To reappoint BF Borgers CPA PC as the auditors of the Corporation for the ensuing year and to authorize the audit committee of the board of directors of the Corporation (the "Board") to fix their remuneration and terms of engagement.
4.To consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution ratifying and confirming By-Law No. 2 of the Corporation, setting advance notice requirements for nominations of directors by shareholders.
5.To consider and, if deemed appropriate, pass a special resolution, the full text of which is set out in the Information Circular (as defined below), approving one or more amendments to the articles of the Corporation for one or more future consolidations of the Corporation's issued and outstanding Common Shares on the basis of consolidation ratios to be selected by the board of directors of the Corporation within a range between 10 pre-consolidation Common Shares for one (1) post-consolidation Common Share and 100 pre-consolidation Common Shares for one (1) post-consolidation Common Share, provided that, (A) the cumulative effect of the one or more consolidations shall not result in a consolidation ratio that exceeds 100 pre-consolidation Common Shares for one (1) post-consolidation Common Share, and (B) such consolidations occurs prior to the earlier of the 12 month anniversary of the Meeting and the next annual meeting of Shareholders; if, and at such time(s) following the date of the Meeting, as may be determined by the board of directors of the Corporation in its sole discretion, as more particularly described in the Information Circular.
6.To consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution confirming and approving the twenty percent (20%) evergreen equity incentive plan of the Corporation.
7.To transact such further or other business as may properly come before the Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2022-06-09 |
股东大会：
将于2022-06-24召开股东大会
会议内容 ▼▲
- 1.To receive the audited consolidated financial statements of the Corporation for the year ended December 31, 2021, together with the auditors' report thereon.
2.To elect the directors of the Corporation for the ensuing year.
3.To reappoint BF Borgers CPA PC as the auditors of the Corporation for the ensuing year and to authorize the board of directors of the Corporation (the "Board") to fix their remuneration and terms of engagement.
4.To transact such further or other business as may properly come before the Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2022-05-02 |
详情>>
业绩披露：
2021年年报每股收益-0.5美元,归母净利润-813.12万美元,同比去年增长-253.79%
|
| 2022-01-31 |
详情>>
业绩披露：
2020年年报每股收益-9.66美元,归母净利润-229.83万美元,同比去年增长-64.8%
|
| 2022-01-31 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-16美元,归母净利润-346.63万美元,同比去年增长-124.49%
|